Effects of capsaicin and isoflavone on blood pressure and serum levels of insulin-like growth factor-I in normotensive and hypertensive volunteers with alopecia

Bioscience, Biotechnology and Biochemistry

Volumn 73, Issue 6, 2009, Pages 1456-1459

  Harada, Naoaki ^a   Okajima, Kenji ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Capsaicin; Hypertension; Insulin like growth factor I; Isoflavone; Sensory neurons

Indexed keywords

CAPSAICIN; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR-I; ISOFLAVONE; SENSORY NEURONS;

BIOACTIVITY; BLOOD; BLOOD PRESSURE; INSULIN; PEPTIDES;

NEURONS;

CAPSAICIN; ISOFLAVONE DERIVATIVE; SOMATOMEDIN C;

ALOPECIA; ARTICLE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DRUG EFFECT; HUMAN; HYPERTENSION; METABOLISM;

ALOPECIA; BLOOD PRESSURE; CAPSAICIN; CASE-CONTROL STUDIES; HUMANS; HYPERTENSION; INSULIN-LIKE GROWTH FACTOR I; ISOFLAVONES;

EID: 67949089783     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.80883     Document Type: Article

References (24)

1. Daughaday WH and Rotwein P., Endocr. Rev., 10, 68-91(1989).
2. Carroll PV, Best Pract. Res. Clin. Endocrinol. Metab., 15, 435-451(2001).
3. Sacca L., Napoli R., and Cittadini A., Clin. Endocrinol. (Oxf), 59, 660-671(2003).
4. Conti E., Carrozza C., Capoluongo E., Volpe M., Crea F., Zuppi C., and Andreotti F., Circulation, 110, 2260-2265(2004).
5. Vecchione C., Colella S., Fratta L., Gentile MT, Selvetella G., Frati G., Trimarco B., and Lembo G., Hypertension, 37, 1480-1485(2001).
6. Lembo G., Rockman HA, Hunter JJ, Steinmetz H., Koch WJ, Ma L., Prinz MP, Ross JJr, Chien KR, and Powell-Braxton L., J. Clin. Invest., 98, 2648-2655(1996).
7. Maggi CA and Meli A., Gen. Pharmacol., 19, 1-43(1988).
8. Dray A., Br. J. Anaesth., 75, 125-131(1995).
9. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J., Vale WW, and Evans RM, Nature, 304, 129-135(1983).
10. Brain SD, Williams TJ, Tippins JR, Morris HR, and Maclntyre I., Nature, 313, 54-56(1985).
11. Okajima K., Harada N., Uchiba M., and Isobe H., J. Pharmacol. Exp. Ther., 309, 684-691(2004).
12. Harada N and Okajima K., Growth Horm. IGF Res., 18, 75-81(2008).
13. Harada N., Okajima K., Arai M., Kurihara H., and Nakagata N., Growth Horm. IGF Res., 17, 408-415(2007).
14. Okajima K and Harada N., Curr. Med. Chem., 13, 2241-2251(2006).
15. Shimozawa N., Okajima K., and Harada N., Am. J. Physiol. Gastrointest. Liver Physiol., 292, G615-619(2007).
16. Whittle BJ and Lopez-Belmonte J., J. Physiol. Pharmacol., 44, 91-107(1993).
17. Van Buren JJ, Bhat S., Rotello R., Pauza ME, and Premkumar LS, Mol. Pain, 1, 17(2005).
18. Leri A., Liu Y., Wang X., Kajstura J., Malhotra A., Meggs LG, and Anversa P., Circ. Res., 84, 752-762(1999).
19. Li J., Kaminski NE, and Wang DH, Hypertension, 41, 757-762(2003).
20. Nguyen TT, Cao N., Short JL, and White PJ, J. Pharmacol. Exp. Ther., 318, 1171-1177(2006).
21. Vitale G., Pivonello R., Auriemma RS, Guerre E., Milone F., Savastano S., Lombardi G., and Colao A., Clin. Endocrinol. (Oxf), 63, 470-476(2005).
22. Messerli FH and Grossman E., Am. J. Cardiol., 93, 7B-12B (2004).
23. Moses AC, Endocr. Dev., 9, 121-134(2005).
24. Bakris GL, Fonseca V., Katholi RE, McGill JB, Messerli FH, Phillips RA, Raskin P., Wright JTJr, Oakes R., Lukas MA, Anderson KM, and Bell DS, JAMA, 292, 2227-2236(2004).